The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 975.00
Bid: 970.00
Ask: 975.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 975.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Jul 2017 07:00

RNS Number : 4974M
CVS Group plc
31 July 2017
 

 

31 July 2017

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2017. All comparative data relates to the year ended 30 June 2016. The Group expects to announce its full year results on Friday 29 September 2017.

 

Revenue and adjusted EBITDA for the recently ended financial year are anticipated to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.3%. This figure reflects particularly strong growth for Animed Direct during the second half of the year as the business responded to management initiatives. Growth in the Veterinary Practices Division has been sustained at more normal levels.

 

The high pace of acquisitions continued in the year to 30 June 2017 with a total of 62 surgeries being acquired. £47.4m (including net debt acquired) was paid for these acquisitions.

 

42 surgeries were acquired in the second half of the year:

 

Practice name

No. of sites

Main locations

Business

Zuid-West Friesland BV

2

Lemmer, Emmelord, (The Netherlands)

Small animal, large animal & equine

Bell Equine Veterinary Clinic

1

Mereworth

Equine

Valley Veterinary Group

2

Kilmarnock

Small animal

Pennine Vets

2

Bolton, Bury

Small animal

Ambivet Veterinary Group

5

Aspley, Heanor, Ilkeston Ripley Woollaton,

Small animal

Willow Veterinary Clinic Norwich

1

Norwich, Norfolk

Small animal

Champion Vet

4

Glasgow, Paisley, East Kilbride and Grangemouth

Small animal

Eagle Veterinary Group

1

Halesworth

Small animal

Animed Veterinary Centre

2

Whitstable, Beltinge

Small animal

Phoenix Vets

2

Camberley, Sandhurst

Small animal

All Creatures Veterinary Health Centre

1

Limavady (Northern Ireland)

Small animal

Shannon Lodge Veterinary Practice

1

Sutton-in-Ashfield

Small animal

Medina Veterinary Group

3

Isle of Wight

Small animal

Severn Edge Veterinary Group

12

Shropshire

Small animal, large animal & equine

Radis Creations BV

3

Zwolle, Henelgo, Amersfoort (Netherlands)

Small animal

 

 

Of particular note in the second half were the acquisitions in the Netherlands of Zuid-West Friesland BV and Radis Creations BV bringing the number of surgeries the Group owns in the Netherlands to nine.

 

In the UK, the acquisition of Severn Edge Veterinary Group gives CVS a strong presence in Shropshire in small animal and large animal, and together with the acquisition of Bell Equine, expands our equine capability significantly.

 

The Group now operates a total of 422 veterinary surgeries (413 in the UK and 9 in the Netherlands), an on-line dispensary, four diagnostic laboratories and seven pet crematoria.

 

CVS continues to see a significant number of acquisition opportunities and is able to focus on those that offer the best potential for the Group. Following this period of high activity, which enabled much of the equity capital raised in December to be deployed, in order to maintain financial flexibility the Group increased its total borrowing facilities to £152.5m (from £115.0m) shortly after the year end. The increased margin payable on the expanded facility is expected to add c.£0.6m p.a. to finance. Net borrowings at 30th June 2017 were £100m.

 

The Board anticipates further like-for-like growth in line with normal levels and the impact of the acquisitions made during the year ended 30 June 2017 will add significantly to the profitability of the Group. Further acquisitions and general progress across all of the Group's divisions are expected.

 

This announcement contains inside information.

 

For further enquiries please contact:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

 

Tel: 020 7496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZNVRFGNZM
Date   Source Headline
3rd Jul 20173:17 pmRNSExercise of Options & TVR
30th Jun 20173:59 pmRNSHolding(s) in Company
30th Jun 20172:57 pmRNSExercise of Options & TVR
2nd Jun 201711:38 amRNSHolding(s) in Company
26th May 20171:43 pmRNSHolding(s) in Company
25th May 20175:33 pmRNSExercise of Options & Total Voting Rights
24th May 20172:12 pmRNSHolding(s) in Company
16th May 20171:52 pmRNSHolding(s) in Company
3rd May 20173:44 pmRNSHolding(s) in Company
2nd May 20172:04 pmRNSExercise of Options and Total Voting Rights
26th Apr 20173:32 pmRNSHolding(s) in Company
3rd Apr 20172:40 pmRNSHolding(s) in Company
31st Mar 201711:55 amRNSDirector/PDMR Dealing
31st Mar 20177:00 amRNSInterim Results
15th Mar 20171:39 pmRNSExercise of Options & TVR - Replacement
14th Mar 20175:29 pmRNSExercise of Options & TVR
13th Mar 20174:07 pmRNSHolding(s) in Company
10th Mar 20172:11 pmRNSHolding(s) in Company
8th Mar 20173:31 pmRNSHolding(s) in Company
3rd Mar 20172:37 pmRNSHolding(s) in Company
28th Feb 201710:30 amRNSPurchase of Shares by Employee Benefit Trust
27th Feb 20174:07 pmRNSExercise of Options & TVR
22nd Feb 20173:13 pmRNSHolding(s) in Company
6th Feb 20175:25 pmRNSExercise of Options & Total Voting Rights
27th Jan 201711:27 amRNSExercise of Options, Director/PCA Dealing & TVR
9th Jan 20179:01 amRNSExercise of Options and Total Voting Rights
19th Dec 20164:48 pmRNSHolding(s) in Company
19th Dec 201612:27 pmRNSHolding(s) in Company
19th Dec 201612:15 pmRNSBlock Admission
14th Dec 20161:01 pmRNSResult of Successful £30.2 million Placing & TVR
13th Dec 201610:32 amRNSClose of Accelerated Bookbuild
13th Dec 20167:00 amRNSProposed Accelerated Bookbuild
6th Dec 20161:07 pmRNSHolding(s) in Company
1st Dec 20165:02 pmRNSHolding(s) in Company
29th Nov 201610:05 amRNSHolding(s) in Company
24th Nov 201611:46 amRNSResult of AGM
24th Nov 20167:00 amRNSAGM Statement
15th Nov 20164:36 pmRNSDirector/PDMR and PCA Shareholding
3rd Nov 20169:49 amRNSPosting of Annual Report and Notice of AGM
31st Oct 201610:23 amRNSDirector/PDMR Shareholding
27th Oct 20164:14 pmRNSHolding(s) in Company
26th Oct 20168:50 amRNSExercise of Options, Directors' Dealing and TVR
25th Oct 20163:30 pmRNSDirector/PDMR Shareholding
25th Oct 20162:41 pmRNSHolding(s) in Company
14th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 20165:13 pmRNSHolding(s) in Company
12th Oct 201611:40 amRNSExercise of Options and Total Voting Rights
11th Oct 20164:37 pmRNSHolding(s) in Company
6th Oct 20163:10 pmRNSHolding(s) in Company
5th Oct 20164:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.